Current Technologies Available for License
Washington Research Foundation’s licensing program works on behalf of not-for-profit research institutions in Washington state. The following links provide overviews of the technologies we currently have available for license.
Expression of Polypeptides in Yeast
Gene Sequences of the Chlamydia trachomatis Major Outer Membrane Protein (MOMP)
Diagnostic Methods for Chlamydia pneumoniae (TWAR)
Gene Sequences of the Chlamydia trachomatis Major Outer Membrane Protein (MOMP)
Use of Interleukin 7 to Improve Vaccine Potency
Simplified High Frequency Broadband Tuner
Contact Us
For additional information about our available technology, please contact:
Beth G. Etscheid, Ph.D.
Director of Licensing
Washington Research Foundation
(206) 336-5600
Expression of Polypeptides in Yeast
Using transformed strains of yeast, recombinant proteins may be produced inexpensively and in large quantities using our patented processes and compositions. Recombinant proteins are commonly used in drugs and vaccines, diagnostics, foodstuffs such as sweeteners and growth enhancers, industrial processes and for drug discovery. Licenses are available for research use only and for commercialization of recombinant proteins by field of use.
Patents covering this technology include:
US Patent No. 5,618,676
US Patent No. 5,854,018
US Patent No. 5,856,123
US Patent No. 5,919,651
For additional information about this technology, please contact:
Beth G. Etscheid, Ph.D.
Director of Licensing
Washington Research Foundation
(206) 336-5600
Gene Sequences of the Chlamydia trachomatis Major Outer Membrane Protein (MOMP)
Chlamydia trachomatis causes a common sexually transmitted disease as well as trachoma, the world’s leading cause of blindness. Researchers at the University of Washington in collaboration with Chiron cloned and expressed the major outer membrane protein (MOMP) of C. trachomatis. Our patents claim the use of the MOMP protein or nucleic acid sequences in vaccines and diagnostics.
Patents covering this technology include:
US Patent No. 5,770,714
US Patent No. 5,821,055
US Patent No. 6,030,799
For additional information about this technology, please contact:
Beth G. Etscheid, Ph.D.
Director of Licensing
Washington Research Foundation
(206) 336-5600
The patents claim immunoassays and nucleic acid-based assays for osteoarthritis, a degenerative disease of the articulating cartilage of joints. The technology is based upon detection of type IIA procollagen protein and mRNA.
Patents covering this technology include:
US Patent No. 5,541,066
US Patent No. 5,780,240
For additional information about this technology, please contact:
Beth G. Etscheid, Ph.D.
Director of Licensing
Washington Research Foundation
(206) 336-5600
Diagnostic Methods for Chlamydia pneumoniae (TWAR)
University of Washington researchers were the first to identify Chlamydia pneumoniae (or TWAR) as a pathogenic organism separate from C. trachomatis and C. psittaci and were the first to develop diagnostic methods for the detection of C. pneumoniae. The patented methods and compositions for direct and indirect organism detection using immunoassays are available for nonexclusive licensing.
These technologies are the subject of this foreign patent, which is available for licensing:
For additional information about this technology, please contact:
Beth G. Etscheid, Ph.D.
Director of Licensing
Washington Research Foundation
(206) 336-5600
Gene Sequences of the Chlamydia trachomatis Major Outer Membrane Protein (MOMP)
Chlamydia trachomatis causes a common sexually transmitted disease as well as trachoma, the world's leading cause of blindness. Researchers at the University of Washington in collaboration with Chiron cloned and expressed the major outer membrane protein (MOMP) of C. trachomatis. Our patents claim the use of the MOMP protein or nucleic acid sequences in vaccines and diagnostics.
Patents covering this technology include:
US Patent No. 5,770,714
US Patent No. 5,821,055
US Patent No. 6,030,799
For additional information about this technology, please contact:
Beth G. Etscheid, Ph.D.
Director of Licensing
Washington Research Foundation
(206) 336-5600
The Caroline Guide is a simple noninvasive medical device that assists a surgeon in the placement of posterior shunts for the treatment of hydrocephalus.
The following patent covers this technology:
For additional information about this technology, please contact:
Beth G. Etscheid, Ph.D.
Director of Licensing
Washington Research Foundation
(206) 336-5600
Use of Interleukin 7 to Improve Vaccine Potency
A patented method for improving the potency of a human or animal vaccine based on administering IL-7 to enhance humoral (antibody-based) immunity.
The following patent covers this technology:
For additional information about this technology, please contact:
Beth G. Etscheid, Ph.D.
Director of Licensing
Washington Research Foundation
(206) 336-5600
Simplified High Frequency Broadband Tuner
By combining direct conversion to baseband with novel tuning and signal processing schemes, this invention achieves advantages such as elimination of the intermediate signals and attendant processing; simplification of processing the near direct current signal due to the use of a novel digital signal processing (DSP) technique; a wider tuning range than is available in superheterodyne receivers; use of the novel signal processing scheme allows the use of inexpensive and readily made bandpass filters; design requirements for the phase locked loop (PLL) are simplified due to a novel tuning technique which is made possible by the novel signal processing scheme; no adjustable or high- precision tuning circuits are required.
Patents covering this technology include:
US Patent No. 5,937,341
US Patent No. 6,427,068
US Patent No. 6,631,256
US Patent No. 7,116,963
US Patent No. 7,606,542
US Patent No. 7,606,549
US Patent No. 7,639,996
US Patent No. 7,853,225
US Patent No. 7,853,239
US Patent No. 7,860,482
US Patent No. 7,925,238
US Patent No. 8,005,450
US Patent No. 8,116,705
US Patent No. 8,140,043
Additional patents are pending.
For additional information about this technology, please contact:
Beth G. Etscheid, Ph.D.
Director of Licensing
Washington Research Foundation
(206) 336-5600
